|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
42.650 +1.000 (+2.401%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 1.83
|
Strong Buy (1)
1
|
Buy (2)
5
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -197.00 RMB (cts) | |
| Net Profit | -515.24 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -756.67 | -270.50 | 0 | -- | -580.00 | -870.00 |
| 2026 | -671.83 | -240.50 | 0 | -- | -385.00 | -789.00 |
| 2027 | -64.50 | -23.10 | 0 | -- | 89.00 | -218.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -580.00 | -222.00 | -- | HAITONG | OutPerform | 70.75 | 28/03/2025 | |
| 2025 | -651.00 | -232.70 | -- | CLSA | High Conviction OP | 65.00 | 28/03/2025 | |
| 2025 | -755.00 | -270.00 | -- | CITIC SEC | Buy | 58.00 | 07/04/2025 | |
| 2025 | -870.00 | -310.90 | -- | BOCOM | Buy | 57.00 | 26/03/2025 | |
| 2025 | -837.00 | -299.00 | -- | CICC | OutPerform | 55.00 | 30/03/2025 | |
| 2025 | -758.33 | -271.00 | -- | HUATAI FIN HLDGS HK | Buy | 54.91 | 11/01/2025 | |
| 2026 | -552.00 | -212.00 | -- | HAITONG | -- | -- | 28/03/2025 | |
| 2026 | -385.00 | -137.70 | -- | CLSA | -- | -- | 28/03/2025 | |
| 2026 | -670.00 | -240.00 | -- | CITIC SEC | -- | -- | 07/04/2025 | |
| 2026 | -789.00 | -282.00 | -- | BOCOM | -- | -- | 26/03/2025 | |
| 2026 | -773.00 | -276.00 | -- | CICC | -- | -- | 30/03/2025 | |
| 2026 | -673.65 | -241.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 11/01/2025 | |
| 2027 | 89.00 | 34.00 | -- | HAITONG | -- | -- | 28/03/2025 | |
| 2027 | 75.00 | 26.80 | -- | CLSA | -- | -- | 28/03/2025 | |
| 2027 | -204.00 | -73.00 | -- | CITIC SEC | -- | -- | 07/04/2025 | |
| 2027 | -218.00 | -77.80 | -- | BOCOM | -- | -- | 26/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 17/04/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -515,241,000 |
| %Change | 43.379% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 8.846 |